By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050


SEARCH JOBS

Teva Pharmaceutical Industries Ltd. develops, produces and markets ethical drugs, generic drugs, and fine chemicals for the pharmaceutical industry and disposable products for hospitals and home care services.


YEAR FOUNDED:

1901

LEADERSHIP:

Founders: Chaim Salomon, Moshe Levin, and Yitschak Elstein

CEO: Erez Vigodman

CEO Global Operations: Carlo de Notaristefani

CEO Global Specialty Medicines: Rob Koremans

CEO Global Generic Medicines: Sigudur (Siggi) Olafsson

CFO: Eyal Desheh

CMO (Medical):

CSO (Scientific): Michael Hayden

JOBS:

Please click here for Teva Pharma job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


PRODUCTS:

All Products


Key Statistics


Email:
Ownership: Public

Web Site: Teva
Employees: 5,700
Symbol: TEVA
 



Industry
Biotechnology






Company News
Teva (TEVA) Ordered To Pay GlaxoSmithKline (GSK) $235 Million In Coreg Patent Row 6/23/2017 6:15:11 AM
Teva (TEVA), USA Extends Voluntary Nationwide Recall To Consumer/User Level For One Lot Of Paliperidone ER Tablets, 3mg, 90 Count Bottles Distributed Under The Actavis Pharma Inc. Label Due To Dissolution Test Failure 6/15/2017 11:01:42 AM
AbCellera Biologics Announces Expanded Research Collaboration With Teva (TEVA) 6/13/2017 8:10:27 AM
Teva (TEVA) Announces Launch Of Generic Zetia In The United States 6/13/2017 7:47:49 AM
Teva (TEVA) Announces Exclusive Launch Of Generic Pataday In The United States 6/9/2017 8:37:24 AM
Struggling Teva (TEVA) Wants To Overhaul Board By Nominating 4 New Directors 6/9/2017 6:31:26 AM
How This Small Washington Biotech Stands To Outperform Rivals Amgen (AMGN), Eli Lilly (LLY) And Teva (TEVA) In Migraine Drugs 6/9/2017 6:04:01 AM
Teva (TEVA)'s Fremanezumab Meets All Primary & Secondary Endpoints Across Both Monthly And Quarterly Dosing Regimens 6/7/2017 7:54:09 AM
Teva (TEVA) To Present Data From 18 Abstracts In Tardive Dyskinesia And Huntington Disease At The 21st International Congress Of Parkinson’s Disease And Movement Disorders 6/1/2017 8:36:32 AM
Teva (TEVA) Announces Positive Results For Phase III Study Of Fremanezumab For The Prevention Of Chronic Migraine 5/31/2017 9:43:11 AM
12345678910...
//-->